Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study
PLoS ONE2016Vol. 11(9), pp. e0161955–e0161955
Citations Over TimeTop 10% of 2016 papers
Nathalie Goemans, M. Tulinius, M. van den Hauwe, Anna‐Karin Kroksmark, Gunnar Buyse, Rosamund Wilson, Judith C. van Deutekom, Sjef J. de Kimpe, Afrodite Lourbakos, Giles Campion
Abstract
ClinicalTrials.gov NCT01910649.
Related Papers
- → Interleucinas na encefalopatia hipóxico-isquêmica(2003)14 cited
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → Genentech taps Affimed’s antibodies(2018)
- Enxerto livre de arteria epigastrica inferior: avaliacao hemodinamica e angiografica pre e pos-operatoria(1988)
- → KOMPLIKASI REGIONAL ANESTESI PADA PEDIATRIK(2023)